Latest News in the pharma Industry

Research & Development

Alkermes Phase II Results of ALKS 3831 Antipsychotic/Lower Weight Gain for Schizophrenia

Alkermes Phase II Results of ALKS 3831 Antipsychotic/Lower Weight Gain for Schizophrenia

8 Jan 2015

Read more 
Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin Platform for Cancer Therapeutics

Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin Platform for Cancer Therapeutics

7 Jan 2015

Read more 
Vectura Signs Global Development and Licence Agreement with Janssen in Asthma/COPD

Vectura Signs Global Development and Licence Agreement with Janssen in Asthma/COPD

6 Jan 2015

Read more 
Bavarian Nordic Initiates Phase I Clinical Trial for the Ebola Vaccine Regimen of MVA-BN Filo and Janssen's AdVac Technology

Bavarian Nordic Initiates Phase I Clinical Trial for the Ebola Vaccine Regimen of MVA-BN Filo and Janssen's AdVac Technology

6 Jan 2015

Read more 
Amgen and Kite Pharma to Collaborate to Advance the Application of Novel Chimeric Antigen Receptor T Cell Therapies

Amgen and Kite Pharma to Collaborate to Advance the Application of Novel Chimeric Antigen Receptor T Cell Therapies

6 Jan 2015

Read more 
Highly Efficient Neural Transfection Reagent

Highly Efficient Neural Transfection Reagent

5 Jan 2015

Read more 
Lundbeck to Research Link Between Immune System and Brain Diseases

Lundbeck to Research Link Between Immune System and Brain Diseases

31 Dec 2014

Read more 
Seeking Single Cells’ Secrets

Seeking Single Cells’ Secrets

31 Dec 2014

Read more 
Stem Cell Transplants May Halt Progression of Multiple Sclerosis

Stem Cell Transplants May Halt Progression of Multiple Sclerosis

30 Dec 2014

Read more 
Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film

Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film

29 Dec 2014

Read more 
FDA Approves Gazyva sBLA with New Data in Previously Untreated Chronic Lymphocytic Leukemia

FDA Approves Gazyva sBLA with New Data in Previously Untreated Chronic Lymphocytic Leukemia

29 Dec 2014

Read more 
Cytokinetics and Astellas Expand Collaboration for Development of CK-2127107 in Spinal Muscular Atrophy and Other Neuromuscular Indications

Cytokinetics and Astellas Expand Collaboration for Development of CK-2127107 in Spinal Muscular Atrophy and Other Neuromuscular Indications

24 Dec 2014

Read more